| BSE: 531762 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE576D01015 |
| BSE 00:00 | 16 Aug | 8.17 |
0 (0.00%) |
OPEN
8.60 |
HIGH
8.60 |
LOW
8.17 |
| NSE 05:30 | 01 Jan | Unjha Formulations Ltd Not listed in NSE |
| OPEN | 8.60 |
| PREVIOUS CLOSE | 8.17 |
| VOLUME | 1700 |
| 52-Week high | 15.92 |
| 52-Week low | 7.27 |
| P/E | 10.61 |
| Mkt Cap.(Rs cr) | 4 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Unjha Formulations was established in Jun.'87 as a partnership firm for manufacturing pharmaceutical formulations in the Mehsana district of Gujarat. It was promoted by Shambhubhai A Patel. The company manufactures pharmaceutical formulations like liquids, powder, tablets, capsules, injectibles, etc. It is one of the largest manufacturers of isabgul products in India. The company's products are...> More
| Parameter | Values | ||
| Market Cap | ( cr) |
4 | |
| EPS - TTM | () |
[*S] | 0.77 |
| P/E Ratio | (X) | [*S] | 10.61 |
| Face Value | () |
10 | |
| Latest Dividend | (%) | - | |
| Latest Dividend Date | - | ||
| Dividend Yield | (%) | 0.00 | |
| Book Value / Share | () |
[*S] | 2.69 |
| P/B Ratio | () |
[*S] | 3.04 |
Un-Audited Financial Results Of The Company For Quarter Ended On 30Th June2018 And Out Come Of Board
Published Notice For Annual General Meeting To Be Held On 28Th August2018 Both News Papers Vide Reg
Notiice For 2Th Annual General Meeting Held On 28Th August 2018 At 10.30 Am At The Regd. Office Of T
Notice Of The 24Th Annual General Meeting To Be Held On 28Th August 2018 At 10.30 A.M. Of The Compan
Intimation Of Book Closure Under Regulation 42 Of The SEBI (LODR)Regulations2015
And Pursuant To
Board Meeting -Date 06.08.2018 ( Un-Audited Financial Results For The Quater Ended On 30.06.2018 Ref
Particulars ( cr) |
Jun 2018 | Jun 2017 | % Chg |
| Net Sales | 3.32 | 3.13 | 6.07 |
| Other Income | - | ||
| Total Income | 3.32 | 3.13 | 6.07 |
| Total Expenses | 3.11 | 3.01 | 3.32 |
| Operating Profit | 0.22 | 0.12 | 83.33 |
| Net Profit | 0.18 | 0.09 | 100 |
| Equity Capital | 4.48 | 4.48 | - |
| Company | Price() |
Chg (%) | Mkt Cap ( CR) |
| Beryl Drugs | 12.85 | 3.63 | 6.51 |
| Ishita Drugs | 18.20 | 4.30 | 5.44 |
| Colinz Labs | 8.99 | 4.66 | 4.11 |
| Pharmaids Pharma | 3.93 | 4.80 | 1.34 |
|
|
|
| Period | BSE | NSE | Sensex | NIFTY |
| 1 Week | -12.99% | NA | 0.18% | 0.38% |
| 1 Month | 0.86% | NA | 3.88% | 4.22% |
| 3 Month | -34.95% | NA | 7.93% | 7.40% |
| 6 Month | -33.03% | NA | 11.54% | 9.77% |
| 1 Year | NA | NA | 19.32% | 15.84% |
| 3 Year | -15.69% | NA | 36.08% | 35.34% |
| Today's Low/High | 8.17 |
|
8.60 |
| Week Low/High | 8.17 |
|
9.00 |
| Month Low/High | 7.27 |
|
10.00 |
| YEAR Low/High | 7.27 |
|
16.00 |
| All TIME Low/High | 1.00 |
|
35.00 |
Promoters
Banks/FIs
FIIs
Insurance
Mutual Funds
Indian Public
Custodians
Other
